Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly GLP1 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
Allowing the vials stopper to naturally adjust after adding bacteriostatic water helps normalize pressure and makes future dosing smoother
Another study in Clinical Gastroenterology and Hepatology showed more than 9% of patients on GLP-1s who underwent esophagogastroduodenoscopy had retained gastric contents, with 78.9% being solid residue
Adipose tissue plays a role in hormone metabolism, and substantial changes in body composition may temporarily affect hormonal balance
Kennedys pharmacy compounding advisory committee, which passes along official recommendation to the broader FDA for approval, suggested that several peptides be moved out of the significant safety risk category, and into one that would allow compounding companies to legally make injectable peptides without backing, and sometimes even without an inspection
10.1038/s41591-025-03799-0 61 JastreboffA